Hormone Replacement Therapy andOvarian Cancers

Authors: L. Ševčík;  J. Klát;  P. Koliba
Authors‘ workplace: Porodnicko-gynekologická klinika, FNsP Ostrava, přednosta MUDr. Peter Koliba, CSc.
Published in: Čes. Gynek.2002, , č. 2 s. 55-58


Analysis of risk and protective factors and hormone replacement therapy in the aethio-logy and pathogenesis of ovarian cancer. The role of hormone replacement therapy in the com-plex treatment in women with ovarian cancer is discussed.Design: Reviewed article.Setting: Department of Obstetrics and Gynaecology, University Hospital Ostrava.Methods: Analysis of epidemiological studies.Conclusion: The role of hormone replacement therapy as a risk factor of ovarian cancer has notbeen confirmed. Hormone replacement therapy as a part of supportive and symptomatic therapyhas been acceptable in a great deal of patients with ovarian cancer.

Key words:
hormone replacement therapy, ovarian cancer

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account